Literature DB >> 3998071

Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis.

J P Hart, M J Shearer, L Klenerman, A Catterall, J Reeve, P N Sambrook, R A Dodds, L Bitensky, J Chayen.   

Abstract

If gamma-carboxylation, by the vitamin K1 - cycle, of glutamate residues of bone-matrix peptides is essential for the formation of bone, the circulating levels of this vitamin might indicate the potential efficiency of this process. Methods involving HPLC with electrochemical detection have very recently been developed for assaying the low levels of vitamin K1 that occur in normal plasma. Using such methods, we found that the circulating levels of vitamin K1 in osteoporotic patients (who had sustained either spinal crush-fractures or fractures of the neck of the femur) were significantly lower than those of age-matched control subjects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3998071     DOI: 10.1210/jcem-60-6-1268

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Vitamin K and metabolic bone disease.

Authors:  C Vermeer; M H Knapen; L J Schurgers
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

2.  Abnormal osteocalcin binding in rheumatoid arthritis.

Authors:  A Fairney; K V Patel; N P Hollings; M H Seifert
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

3.  No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women.

Authors:  L Rejnmark; P Vestergaard; P Charles; A P Hermann; C Brot; P Eiken; L Mosekilde
Journal:  Osteoporos Int       Date:  2006-05-09       Impact factor: 4.507

Review 4.  Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.

Authors:  John A Batsis; Dennis T Villareal
Journal:  Nat Rev Endocrinol       Date:  2018-09       Impact factor: 43.330

5.  Comparison of inhibitory effects of warfarin on gamma-carboxylation between bone and liver in rats.

Authors:  Kuniko Hara; Masatoshi Kobayashi; Yasuhiro Akiyama
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

6.  Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.

Authors:  P Szulc; M C Chapuy; P J Meunier; P D Delmas
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

7.  Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study.

Authors:  Masataka Shiraki; Akira Itabashi
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

8.  Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women.

Authors:  M H J Knapen; L J Schurgers; C Vermeer
Journal:  Osteoporos Int       Date:  2007-02-08       Impact factor: 4.507

9.  Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules.

Authors:  Tetsuo Inoue; Toshiharu Fujita; Hideaki Kishimoto; Toshitaka Makino; Tetsuro Nakamura; Toshitaka Nakamura; Tosiya Sato; Kaoru Yamazaki
Journal:  J Bone Miner Metab       Date:  2008-12-12       Impact factor: 2.626

10.  Influence of bone osteocalcin levels on bone loss induced by ovariectomy in rats.

Authors:  Kuniko Hara; Masatoshi Kobayashi; Yasuhiro Akiyama
Journal:  J Bone Miner Metab       Date:  2007-10-25       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.